InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
1
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the complete record of transactions filed by O'Keefe Kenneth W, Directeur. Director active across 1 company, notably Jazz Pharmaceuticals plc. Cumulatively, 8 filings have been published. Split: 0 buy · 1 sell. Total volume traded: €163k. History available since 29 July 2021. The latest transaction was filed on 2 December 2025 (Retenue fiscale). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to O'Keefe Kenneth W
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations8 total
603 shares@ US$173.0715.0% of flowOrdinary SharesSEC:0001397661-25-000009:0
3,507 shares0Ordinary SharesSEC:0001765581-25-000096:0
3,731 shares0Ordinary SharesSEC:0001765581-24-000075:0
3,075 shares0Ordinary SharesSEC:0001765581-23-000096:0
4,500 shares@ US$81.7651.3% of flowOrdinary SharesSEC:0001765581-23-000034:0
2,561 shares0Ordinary SharesSEC:0001765581-22-000092:0
1,306 shares@ US$147.9627.3% of flowOrdinary SharesSEC:0001765581-21-000106:0
2,246 shares0Ordinary SharesSEC:0001765581-21-000077:0
8 of 8 declarations
About O'Keefe Kenneth W
O'Keefe Kenneth W is Director of Jazz Pharmaceuticals plc (XNAS). He has filed 8 reports in total, and among the 8 most recent filings observed, the transactions cover the period from 2021-08-02 to 2025-12-04, with EUR 0 of purchases and EUR 163265 of sales; the most common transaction nature is Attribution.
